Somatic specialist healthcare
2024
2025
Scale: 0–1,600,000 patients.
Explore how healthcare services are used, how disease burden and health vary, and what research and statistics tell us. Figures come from different sources and must be interpreted according to what they actually measure.
How many people use GPs, out-of-hours emergency care and specialist healthcare? The charts distinguish consultations, patients and percentages.
Back to the topic overviewStatistics Norway · Out-of-hours emergency care · Women
Here you can see the proportion of women who had no, exactly one or at least two out-of-hours emergency consultations in each year. The figures are percentages of women of all ages, not counts of consultations.
How to read the chart
Each horizontal bar represents 100 women. Dark blue shows how many had no consultations, medium blue those who had one, and light blue the remainder with two or more. The parts add up to 100%.
The proportion with two or more consultations is found by subtracting the proportions with no consultations and with one consultation from 100 percent. All three groups concern the same population. Small differences may be due to rounding.
On mobile, swipe the table horizontally to see all columns.
| Year | Proportion of people with 0 out-of-hours emergency consultations (percent) | Proportion of people with 1 out-of-hours emergency consultation (percent) | Two or more (calculated) |
|---|---|---|---|
| 2020 | 83.2 | 12.4 | 4.4 |
| 2021 | 83.1 | 12.5 | 4.4 |
| 2022 | 83 | 12.5 | 4.5 |
| 2023 | 83.3 | 12.4 | 4.3 |
| 2024 | 83.2 | 12.4 | 4.4 |
| 2025 | 83.6 | 12.2 | 4.2 |
Choose an age group to compare percentages across years. Only the available figures from the restricted Statistics Norway extract are shown here.
Each bar represents 100 women in the selected age group. The parts show the proportion with no, one and at least two consultations during the year.
The proportion with two or more consultations is calculated as the remainder up to 100%. This assumes that the measures cover the same population and do not overlap. Small differences may result from rounding.
| Year | Proportion of people with 0 out-of-hours emergency consultations (percent) | Proportion of people with 1 out-of-hours emergency consultation (percent) |
|---|---|---|
| 2020 | 76.9 | 16.6 |
| 2021 | 72.1 | 18.6 |
| 2022 | 70.6 | 19.7 |
| 2023 | 72.4 | 18.9 |
| 2024 | 72.7 | 18.8 |
| 2025 | 73.6 | 18.2 |
Select year and measure to compare the recorded percentages across age groups.
All bars use the same scale from 0 to 100%. Different age groups have different population sizes. Differences in proportions alone do not establish differences in health needs or quality of care.
The file contains all selected age groups, years and both measures, with Statistics Norway as the original source and Tidlignok / Womanhood Initiative as the presenter. Missing values remain blank.
The first view shows percentages for one selected age group of women. Age groups remain as defined by Statistics Norway. The percentages describe recorded use of out-of-hours emergency care, not healthcare needs or treatment quality.
The figures show how many out of 100 women had zero, one or at least two registered out-of-hours emergency consultations during a year. The 'two or more' category is calculated from the two published percentages and must not be interpreted as a count of consultations. The figures do not explain reasons for using out-of-hours care or the need for healthcare.
Source: Statistics Norway, table 10310. The table shows a specific extract from Statistics Norway. Newer figures may be available in its statistical database.
Statistics Norway · Healthcare
Here you can see how many people use different healthcare services and how that use has changed. We distinguish between patient counts, consultations per person and percentages because they describe different aspects of healthcare.
Average number of consultations per person per year, 2012–2025. In 2025, women had an average of 3.6 consultations, while men had 2.4.
The vertical axis starts at zero. These are consultations per person, not the total number of consultations or the proportion who visited a GP.
| Year | Women | Men |
|---|---|---|
| 2012 | 3.1 | 2.2 |
| 2013 | 3.0 | 2.2 |
| 2014 | 3.1 | 2.2 |
| 2015 | 3.1 | 2.2 |
| 2016 | 3.1 | 2.2 |
| 2017 | 3.1 | 2.2 |
| 2018 | 3.1 | 2.2 |
| 2019 | 3.2 | 2.2 |
| 2020 | 3.4 | 2.3 |
| 2021 | 3.6 | 2.4 |
| 2022 | 3.6 | 2.4 |
| 2023 | 3.6 | 2.4 |
| 2024 | 3.6 | 2.4 |
| 2025 | 3.6 | 2.4 |
Source: Statistics Norway, General practitioner services, Figure 6: GP consultations by sex, 2012–2025. Published in 2026. The differences show recorded use of services, not necessarily differences in treatment needs or access.
Proportion of people who had at least one out-of-hours emergency consultation during the year. We compare 2019 and 2025, not a continuous annual series.
Both bar charts use an axis from 0 to 100 percent. The percentage refers to people, not the proportion of all consultations.
| Year | Women | Men |
|---|---|---|
| 2019 | 18 % | 16 % |
| 2025 | 16 % | 15 % |
Sources: Statistics Norway, GP services (2025 figures) and Statistics Norway, corresponding table for 2019. Source table 10310. The changes show recorded contacts with out-of-hours emergency services, not direct changes in disease prevalence or accessibility.
Number of people receiving treatment in Norway in 2024 and 2025, broken down by sex. These are not counts of consultations or rates per inhabitant. Service areas have separate scales and must not be added together: the same person may have received treatment in both.
2024
2025
Scale: 0–1,600,000 patients.
2024
2025
Scale: 0–160,000 patients.
| Year | Somatic care, women | Somatic care, men | Mental healthcare, women | Mental healthcare, men |
|---|---|---|---|---|
| 2024 | 1,450,461 | 1,206,396 | 123,627 | 77,913 |
| 2025 | 1,484,946 | 1,231,272 | 122,457 | 76,704 |
Statistics Norway's source tables have annual figures from 2015 to 2025. The charts above show key figures for 2024–2025. The detailed annual series can be explored by sex and age further down the page when the local Statistics Norway files are available. We do not interpolate figures.
For adult mental healthcare (table 14820), the age groups are 18–29, 30–49, 50–66 and 67 years or older. Somatic care (table 14824) must be checked using its own age categories. In later comparisons, we must distinguish patient counts from patients per inhabitant and consider changes in the registration of national identity numbers.
Source: SSB, Patients in specialist healthcare, Table 1, updated 22 June 2026 (StatBank tables 14820 and 14824). The figures cover somatic care and adult mental healthcare, not child and adolescent mental healthcare or interdisciplinary specialist substance-use treatment. Only people with a valid national identity or D-number are included. The scope may be affected by recording practices. The counts do not measure treatment needs or waiting times.
Statistics Norway distinguishes between outpatients and inpatients. The groups overlap: one person may be included in several treatment categories. The figures are not counts of treatments.
2024
2025
2024
2025
2024
2025
Bars start at zero and are scaled separately for each treatment category, so magnitudes cannot be compared visually across panels.
| Type of treatment | Year | Women | Men |
|---|---|---|---|
| Outpatients, somatic care | 2024 | 1,386,297 | 1,143,963 |
| Outpatients, somatic care | 2025 | 1,422,735 | 1,170,033 |
| Inpatients, somatic care | 2024 | 316,626 | 259,338 |
| Inpatients, somatic care | 2025 | 319,836 | 260,880 |
| Inpatients, adult mental healthcare | 2024 | 13,680 | 13,227 |
| Inpatients, adult mental healthcare | 2025 | 13,527 | 12,849 |
Source: SSB, Patients in specialist healthcare, tabell 1, oppdatert 22. juni 2026. Annual series by sex and age are available in the explorer below when the Statistics Norway files are accessible.
Adult mental healthcare
Official Statistics Norway figures for patient counts, not consultations or patients per inhabitant. Select sex and age group to follow trends within the same category. Different age groups cannot be compared directly without accounting for population size.
| Year | Patients |
|---|---|
| 2015 | 111,561 |
| 2016 | 114,861 |
| 2017 | 115,341 |
| 2018 | 115,611 |
| 2019 | 116,763 |
| 2020 | 117,747 |
| 2021 | 123,891 |
| 2022 | 127,551 |
| 2023 | 127,476 |
| 2024 | 123,630 |
| 2025 | 122,457 |
Source: Statistics Norway table 14820. Annual figures are displayed only when a local extract is available. Comparing patient counts is not the same as comparing population-adjusted rates.
The figures include different kinds of contact with healthcare. Numbers of people, numbers of consultations and population percentages are different measures. The charts therefore show what was measured, the reference period and the groups included.
SSB · tabell 14820
The table can be broken down by sex. Individual charts specify the population used.
SSB · tabell 14824
The table can be broken down by sex. Individual charts specify the population used.
SSB · tabell 09535
The table can be broken down by sex. Individual charts specify the population used.
SSB · tabell 10310
The table can be broken down by sex. Individual charts specify the population used.
When comparing figures over time, groups, recording practices and units of measurement must be consistent. Changes in patient counts may also reflect population size and who seeks healthcare.
Statistics Norway · Table 10310 · 2025
This shows the average number of out-of-hours emergency consultations per person in 2025 within each age group. This is a different measure from the proportion who had at least one out-of-hours emergency consultation, which is already shown further up the page.
0–5 years
6–15 years
16–19 years
20–29 years
30–49 years
50–66 years
67–79 years
80–89 years
90 years og eldre
Common scale: 0–0.50 consultations per person. Age groups follow Statistics Norway's classification.
| Age | Women | Men |
|---|---|---|
| 0–5 years | 0.40 | 0.47 |
| 6–15 years | 0.18 | 0.19 |
| 16–19 years | 0.31 | 0.21 |
| 20–29 years | 0.30 | 0.21 |
| 30–49 years | 0.21 | 0.17 |
| 50–66 years | 0.18 | 0.17 |
| 67–79 years | 0.23 | 0.22 |
| 80–89 years | 0.34 | 0.35 |
| 90 years og eldre | 0.37 | 0.47 |
These figures are average out-of-hours emergency consultations per person within each age and sex group, not the proportion who visited out-of-hours care. Age groups follow Statistics Norway's own definitions and cannot be added together. Figures have two decimal places as published by Statistics Norway. Differences in use alone do not indicate differences in treatment needs or access.
Open Statistics Norway's original table 10310Original source: Statistics Norway, table 10310, updated 28 May 2026. Presented by Tidlignok, Womanhood Initiative. Checked on 4 November 2026.
See how long patients wait and how activity measures change. Some figures cover all patients and cannot be used to describe women separately.
Back to the topic overviewFHI · Norwegian Patient Registry
Waiting time is the average number of days before healthcare begins. The figures cover all patients, regardless of sex, and do not show waiting times separately for girls or women. Nor do they describe how long each individual patient waits.
Shared scale: 0–90 days.
Shared scale: 0–90 days.
Shared scale: 0–90 days.
Shared scale: 0–90 days.
| Service area | Year | Waiting time in days | Patients |
|---|---|---|---|
| Somatic care | 2023 | 75 | 2,659,384 |
| Somatic care | 2024 | 77 | 2,688,657 |
| Somatic care | 2025 | 68 | 2,739,878 |
| Adult mental healthcare | 2023 | 54 | 211,540 |
| Adult mental healthcare | 2024 | 55 | 205,196 |
| Adult mental healthcare | 2025 | 46 | 202,444 |
| Child and adolescent mental healthcare | 2023 | 55 | 71,460 |
| Child and adolescent mental healthcare | 2024 | 52 | 72,317 |
| Child and adolescent mental healthcare | 2025 | 41 | 75,027 |
| Interdisciplinary specialist substance-use treatment | 2023 | 33 | 34,360 |
| Interdisciplinary specialist substance-use treatment | 2024 | 30 | 33,982 |
| Interdisciplinary specialist substance-use treatment | 2025 | 26 | 33,313 |
A person may receive healthcare in several service areas and therefore be included in multiple patient counts. The sum across service areas is consequently not a count of unique patients across all specialist healthcare. Waiting time is a different measure from the number of patients.
Sources: FHI, annual statistics 2023–2024 og FHI, annual statistics 2024–2025, published 17 March 2026.
FHI · Norwegian Patient Registry · 2026
This compares corresponding periods in 2025 and 2026, not annual figures. Patient counts cover January–August. Waiting times cover the second four-month period (May–August). Patient counts and average waiting times therefore refer to different measurement periods.
Average waiting time, second four-month period
Scale: 0–70 days.
Patients January–August
Patient counts have their own scale within each service area.
Average waiting time, second four-month period
Scale: 0–70 days.
Patients January–August
Patient counts have their own scale within each service area.
Average waiting time, second four-month period
Scale: 0–70 days.
Patients January–August
Patient counts have their own scale within each service area.
Average waiting time, second four-month period
Scale: 0–70 days.
Patients January–August
Patient counts have their own scale within each service area.
| Service area | Patients Jan–Aug 2025 | Patients Jan–Aug 2026 | Waiting time, second four-month period 2025 | Waiting time, second four-month period 2026 |
|---|---|---|---|---|
| Somatic care | 2,262,292 | 2,246,285 | 63 days | 63 days |
| Adult mental healthcare | 169,107 | 166,874 | 43 days | 43 days |
| Child and adolescent mental healthcare | 63,791 | 64,594 | 41 days | 42 days |
| Interdisciplinary specialist substance-use treatment | 28,478 | 29,172 | 26 days | 26 days |
Activity figures are preliminary, while waiting-list figures are final for the stated periods. The same patient may be included in several service areas. Source: FHI, waiting times and activity at the end of August 2026.
Participation in screening and vaccination reflects uptake of preventive services, not on its own how many people are ill.
Back to the topic overviewFHI · Prevention
In 2025, 72.7 percent of women aged 25–69 participated in the Norwegian Cervical Screening Programme within the recommended screening interval. A total of 353,435 cervical samples were registered, including samples taken because of symptoms and follow-up samples, and 259 new cases of cervical cancer were recorded. The sample count is not the number of participants.
Participation within recommended interval
Cervical samples in 2025
New cases of cervical cancer in 2025
According to the 2025 annual report, women aged 25–33 had the lowest participation in the Norwegian Cervical Screening Programme, and the decline among the youngest participants continued. The programme's target is at least 80 percent participation. We do not display percentages by age or county until the specific figures have been retrieved and verified. Sample counts and participation percentages have different denominators.
FHI also reports that completed HPV vaccination among 16-year-old girls rose from 67 percent in 2013 to 93 percent in 2024. Among 16-year-old boys, coverage was 90 percent in 2024. These figures measure vaccination, not HPV prevalence.
Mammography figures are shown in the next section. The programmes cover different age groups and use different measures of participation.
FHI · Norwegian Cervical Screening Programme · annual report 2025
What proportion of women in each age group had at least one registered cervical sample during the five-year period 2021–2025? We show the age groups covered by the Norwegian Cervical Screening Programme, ages 25–69.
Common scale: 0–100 percent. The bars show the proportion of women in each age group over five years, not the proportion tested in 2025 alone.
| Age | Proportion |
|---|---|
| 25–29 years | 67.6 % |
| 30–34 years | 78.8 % |
| 35–39 years | 83.7 % |
| 40–44 years | 80.2 % |
| 45–49 years | 77.3 % |
| 50–54 years | 76.6 % |
| 55–59 years | 76.7 % |
| 60–64 years | 73.9 % |
| 65–69 years | 69.7 % |
Important: This is five-year coverage for different age groups, not FHI's 'participation within the recommended screening interval' indicator of 72.7 percent. Nor should the figures be interpreted as meaning a screening sample was always required throughout the five-year period. The screening method and recommended intervals have changed.
Source: FHI, Norwegian Cervical Screening Programme annual report 2025, Table 3.4. The report describes changes in HPV screening and coverage calculations. Original figures checked on 3 November 2026.
Open the original FHI report and Table 3.4FHI · BreastScreen Norway
In 2025, approximately 332,300 women were invited. Of those invited, 78.8 percent attended. The programme invites women aged 50–69. This is the proportion of invited women who attended, not the proportion of all women in Norway.
Shared bar scale: 0–100 percent.
| Year | Proportion of invitees who attended |
|---|---|
| 2023 | 76.7 % |
| 2024 | 76.9 % |
| 2025 | 78.8 % |
Oslo
72.8 %Nordland
82.5 %Agder
80.6 %Three selected breast centre areas, not a complete ranking. The areas are defined by BreastScreen Norway.
Source: FHI, key figures for BreastScreen NorwayWomen and men may have different lifespans and disease burdens. Life expectancy, healthy life years and years lived with disability are distinct measures.
Back to the topic overviewStatistics Norway · Eurostat/Bufdir · Norway
Life expectancy indicates how long newborns could expect to live if mortality remained at the level observed in the reference year. Healthy life years is a different measure: the number of years a person can expect to live without activity limitations due to health problems.
Women: 84.85 years
Men: 81.61 years
Women had life expectancy 3.24 years higher than men.
Women: 62.3 years
Men: 67.0 years
Men had 4.7 more expected years without activity limitations. The source uses a different definition and reference year from the life expectancy figure.
Statistics Norway, 2015–2025. The bars start at zero and show life expectancy at birth in each calendar year.
Global Burden of Disease estimated healthy life expectancy at 70.8 years for women and 70.3 years for men in Norway in 2023. This is a different measure from Eurostat's years without activity limitations and must not be compared as the same series.
Source: FHI, Burden of disease in Norway (GBD 2023)Healthy life years are based on information about activity limitations and estimated life expectancy. They are not years completely free of illness. Years lived with disability (YLD), by contrast, measures disease burden by weighting different health conditions according to severity. These measures cannot be added together or treated as measuring the same thing.
A comparable time series for healthy life years and a source-verified YLD series will only be added once all annual figures, restrictions and definitions have been confirmed.
Sources: Statistics Norway: Life expectancy 1950–2025 and Bufdir: Healthy life years (Eurostat). Eurostat's latest year in this extract is 2024. Life expectancy, healthy life years and FHI's YLD/HALE have different reference years and definitions.
Eurostat · Norway · hlth_hlye
Here, healthy life years means the expected number of years without activity limitations due to health problems. This measure is based on EU statistics and must not be confused with FHI's estimates of healthy life expectancy (HALE) or years lived with disability (YLD).
Missing values are shown with a dash (2021). * Eurostat flags 2023 with 'b', indicating a break in the time series. The figures are shown for transparency, but changes across this break must not be interpreted as a directly comparable trend. Source data may subsequently be revised.
Source: Eurostat hlth_hlye, indicator HLY_Y0, unit: years, Norway.
FHI · Global Burden of Disease 2023
Years lived with disability (YLD) is an estimated measure of how disease and injury affect health during life. The figures below cover all ages and causes of disease in Norway. They do not show how many people are ill.
Women
Approx. 305,000
Estimated years lived with disability · 2023
Men
Approx. 257,000
Estimated years lived with disability · 2023
The difference is approximately 48,000 estimated years lived with disability, but these are absolute figures. Population size and age distribution must be considered before comparing risk or disease burden per person.
YLD is not the same as life expectancy, Eurostat's years without activity limitations or GBD's healthy life expectancy (HALE). Annual figures are rounded in FHI's account. HelseOmsorg21 Monitor reports YLD and DALY at five-year intervals from 1990, with 2023 the latest year in the relevant data display. Years absent from the source must not be constructed. A separate time-series chart requires verified original figures for both sexes and editorial approval.
Source: FHI, Burden of disease in Norway (GBD 2023). Source figures are approximate. The historical points from FHI's GBD estimates are not shown here as a separate chart. HelseOmsorg21 Monitor: disease burden by sex.
WHO · Global Health Estimates 2023 · 2026 edition
The values come from WHO's original tables for Norway, covering all ages and all causes. They show estimated years lived with disability (YLD). These figures are not counts of people with illnesses, nor are they FHI's GBD series.
Women · 2023
428,172 years
Men · 2023
354,294 years
Scale: 0–500,000 estimated years lived with disability. The years are unevenly spaced; no values for intervening years have been estimated in this display. Figures are rounded to the nearest whole year lived with disability.
| Year | Women | Men |
|---|---|---|
| 2000 | 319,119 | 255,044 |
| 2010 | 349,542 | 286,623 |
| 2015 | 371,990 | 308,805 |
| 2019 | 391,014 | 321,882 |
| 2020 | 401,710 | 329,646 |
| 2021 | 408,771 | 336,835 |
| 2022 | 418,527 | 346,391 |
| 2023 | 428,172 | 354,294 |
Source: WHO Global Health Estimates 2023, released in 2026. The original files cover 2000, 2010, 2015 and 2019–2023. The values come from the 'All ages' worksheet, the 'All Causes' rows and the NOR column, converted from thousands of years lived with disability into years lived with disability. They are not age-standardised rates and may be affected by changes in population size and age distribution.
WHO Global Health Estimates · Documented original extract on GitHub. GHE and GBD use different methods and produce different estimates; these figures must not be combined.
NAV · Working life and health
In 2025, doctor-certified sickness absence was 7.2 percent among women and 4.1 percent among men. The corresponding figures in 2024 were 7.5 and 4.3 percent. The percentage represents working days lost relative to contracted working days, not the proportion of people who were ill.
2024
2025
Shared scale: 0–8 percent for both years and both sexes.
| Year | Women | Men |
|---|---|---|
| 2024 | 7.5% | 4.3% |
| 2025 | 7.2% | 4.1% |
The difference between the sexes alone cannot explain which diagnoses or working conditions underlie it. NAV publishes separate tables by age, diagnosis, industry and occupation. These must be verified separately before we display more detailed charts.
Source: NAV annual statisticsNAV · 2002–2025
Annual share of scheduled working days lost to medically certified sickness absence, by sex. These are not counts of people.
| Year | Women | Men | Both |
|---|---|---|---|
| 2002 | 7.9 % | 5.2 % | 6.4 % |
| 2003 | 8.4 % | 5.6 % | 6.8 % |
| 2004 | 7.2 % | 4.6 % | 5.8 % |
| 2005 | 6.6 % | 4.2 % | 5.3 % |
| 2006 | 7.0 % | 4.3 % | 5.5 % |
| 2007 | 7.0 % | 4.2 % | 5.5 % |
| 2008 | 7.2 % | 4.4 % | 5.6 % |
| 2009 | 7.4 % | 4.7 % | 5.9 % |
| 2010 | 6.8 % | 4.2 % | 5.3 % |
| 2011 | 6.8 % | 4.0 % | 5.3 % |
| 2012 | 6.6 % | 3.8 % | 5.1 % |
| 2013 | 6.5 % | 3.8 % | 5.0 % |
| 2014 | 6.5 % | 3.7 % | 5.0 % |
| 2015 | 6.2 % | 3.6 % | 4.8 % |
| 2016 | 6.1 % | 3.5 % | 4.7 % |
| 2017 | 6.4 % | 3.6 % | 4.9 % |
| 2018 | 6.2 % | 3.5 % | 4.8 % |
| 2019 | 6.3 % | 3.6 % | 4.8 % |
| 2020 | 6.7 % | 3.9 % | 5.2 % |
| 2021 | 6.8 % | 3.8 % | 5.2 % |
| 2022 | 7.0 % | 4.1 % | 5.4 % |
| 2023 | 7.2 % | 4.2 % | 5.6 % |
| 2024 | 7.5 % | 4.3 % | 5.8 % |
| 2025 | 7.2 % | 4.1 % | 5.5 % |
Source: NAV Annual Report 2025, Figure 2. This is medically certified absence, not total absence including self-certification. NAV source
NAV · 2025
Medically certified absence as a percentage of scheduled working days in 2025, not the percentage of people who were on sick leave.
16–19 yrs
20–24 yrs
25–29 yrs
30–34 yrs
35–39 yrs
40–44 yrs
45–49 yrs
50–54 yrs
55–59 yrs
60–64 yrs
65–69 yrs
All bars use the same 0–10% scale. Top bar in each age band: women; bottom bar: men.
| Age | Women | Men |
|---|---|---|
| 16–19 | 2.2 % | 2.0 % |
| 20–24 | 4.7 % | 2.9 % |
| 25–29 | 7.1 % | 3.2 % |
| 30–34 | 8.6 % | 3.7 % |
| 35–39 | 8.0 % | 4.0 % |
| 40–44 | 7.1 % | 4.1 % |
| 45–49 | 6.9 % | 4.2 % |
| 50–54 | 7.1 % | 4.4 % |
| 55–59 | 7.3 % | 5.0 % |
| 60–64 | 7.9 % | 5.8 % |
| 65–69 | 6.5 % | 5.1 % |
Source: NAV, Annual Report on Medically Certified Sickness Absence 2025, Figure 7. These figures exclude self-certified absence. Original NAV statistics
An estimate of how many people have a condition is different from the number who have had the diagnosis recorded. These measures are distinguished here.
Back to the topic overviewHelsenorge and FHI · Gynaecological health
Approximately 10%
Helsenorge's estimate for women of reproductive age. The actual prevalence is unknown. This figure is not based on a complete Norwegian count of diagnoses.
Approximately 10 percent is an estimate of how many may have endometriosis. Registry figures, by contrast, show how many people have had the diagnosis recorded in healthcare services. Undiagnosed people are not included in registry figures.
FHI has also described a range of 6–10 percent for endometriosis. There is no complete Norwegian count of everyone with the condition. A registry study can only show diagnoses recorded in a specific period and service, and therefore must not be interpreted as prevalence in the entire population.
Adenomyosis, PCOS, vulvodynia and heavy menstrual bleeding have their own definitions and data sources. The estimate for endometriosis does not apply to these conditions.
Norwegian Patient Registry · registry study 2008–2021
A Norwegian registry study included 1,910,661 women aged 15–49. It examined diagnoses recorded in specialist healthcare services between 2008 and 2021.
1.5%
27,773 women
Recorded endometriosis
0.3%
5,432 women
Recorded adenomyosis
0.2%
3,029 women
Recorded with both diagnoses
The group with both diagnoses overlaps the other two categories and must not be added as a separate group. The figures show recorded diagnoses, not how many people actually have the conditions. Undiagnosed people are not captured. The study covers a total of 14 years and is not an annual statistic for 2025.
Source: Journal of the Norwegian Medical Association, 2025Health Atlas · SKDE · Women aged 16–55
SKDE reports 1,272 procedures in 2015 and 2,431 procedures in 2024, an increase of 91%. We show these two explicitly published years, not a continuous time series. The figures concern surgical procedures, not the number of women living with endometriosis.
Common scale: 0–2,500 procedures.
SKDE also finds considerable geographic variation: the hospital catchment area with the highest procedure rate had a rate around four times that of the lowest in 2025. Catchment areas are not the same as counties. We do not show a separate geographic chart without verified rates by catchment area.
SKDE reports approximately 2.5 procedures per 1,000 women in Vestfold and 0.6 per 1,000 in Førde and Nord-Trøndelag in 2019–2021. These are hospital catchment areas, not counties, and the figures are not from 2025.
Shared scale: 0–3 per 1,000 women. These regional rates cannot be compared directly with national operation counts. SKDE historical analysis.
| Year | Procedures |
|---|---|
| 2015 | 1,272 |
| 2024 | 2,431 |
These are two explicitly published comparison years, not a complete annual series. Procedure counts measure neither the prevalence of endometriosis nor geographically adjusted rates. Variation between catchment areas cannot be inferred from national counts alone.
Original source: SKDE / Health Atlas. Presented by Tidlignok, Womanhood Initiative. Figures checked against SKDE's published analysis on 4 November 2026.
The Norwegian Patient Registry shows recorded diagnoses, but not how long it took from first symptoms to diagnosis. Norwegian and international studies have examined diagnostic delays. An open question is, among other things, who waits the longest in Norway today.
Explore available information about diagnoses recorded in specialist healthcare. The figures describe registered patients and contacts with services, not necessarily how many people in the population have a condition.
Back to the topic overviewFHI · NPR · 2017–2025
Choose one diagnosis family and year. Each row counts patients recorded with that exact code in specialist care. A patient may appear in multiple rows; never add the bars together.
The original NPR tables 545/546 do not provide age, sex or county dimensions. Such breakdowns would require an additional aggregated source extract.
Shared zero-based scale for codes within the selected year and diagnosis group. Bars cannot be added together.
| Code | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| N800 | 517 | 675 | 662 | 699 | 704 | 824 | 1,002 | 982 | 1,216 |
| N801 | 973 | 1,068 | 1,032 | 1,097 | 1,065 | 1,038 | 1,010 | 1,086 | 1,145 |
| N802 | 53 | 31 | 29 | 27 | 30 | 37 | 30 | 24 | 38 |
| N803 | 986 | 1,030 | 1,061 | 1,206 | 1,269 | 1,504 | 1,811 | 1,952 | 2,126 |
| N804 | 101 | 121 | 107 | 95 | 119 | 130 | 140 | 167 | 163 |
| N805 | 74 | 101 | 134 | 123 | 128 | 162 | 184 | 157 | 177 |
| N806 | 60 | 39 | 50 | 60 | 54 | 55 | 66 | 67 | 74 |
| N808 | 331 | 348 | 341 | 332 | 395 | 380 | 411 | 452 | 530 |
| N809 | 2,441 | 2,636 | 2,986 | 2,917 | 3,131 | 3,666 | 3,746 | 3,682 | 4,184 |
FHI Norwegian Patient Registry, tables 545/546, measure ANT_PAS. Registered specialist-care patients by diagnosis code, not prevalence. Recording can change over time; suppressed data are not zero. Original source
FHI · Norwegian Patient Registry · 2017–2025
Explore registered patients by diagnosis code from 2017 to 2025. Choose one of six diagnosis groups and then a specific code. These are specialist healthcare figures, not counts of people living with the condition in Norway.
Measure: number of registered patients per calendar year. Shared scale across all nine years for the selected diagnosis.
Change from 2024 to 2025
234 more registered patients in 2025 than in 2024 for this diagnosis code.
Changes over time may reflect diagnosis, referrals, changes in healthcare services and recording practices. This is not a direct measure of disease prevalence or individual risk.
| Year | Registered patients |
|---|---|
| 2017 | 517 |
| 2018 | 675 |
| 2019 | 662 |
| 2020 | 699 |
| 2021 | 704 |
| 2022 | 824 |
| 2023 | 1,002 |
| 2024 | 982 |
| 2025 | 1,216 |
Original source: FHI, Norwegian Patient Registry, ICD-10 condition codes, table 545. All providers (3), service area 9000, measure ANT_PAS. Figures are annual values from 2017 to 2025 without separate breakdown by sex, age or residence.
FHI describes generally good data quality for somatic specialist healthcare, but coding quality and completeness may vary across variables and periods. Figures for different years must therefore be interpreted cautiously. We have not adjusted for changes in coding, services or patient characteristics.
A patient can have multiple diagnosis codes. Codes therefore cannot be summed to count unique patients. Diagnosis codes describe contact with specialist healthcare, not prevalence in the population.
The historical extract contains 441 source cells in total (431 numerical values and 10 suppressed/missing). All 98 values for 2024–2025 were checked against previous original extracts without discrepancies. Suppressed values are never shown as zero.
Source data last updated: 24 March 2026. Historical original extract and verification: 3 November 2026. Documented source verification covers codes, selections, annual values and overlap, but is not a full audit of historical recording practices.
Open the original FHI tableFHI · Norwegian Patient Registry · 2017–2025
Explore selected diagnosis codes directly related to pregnancy and childbirth, including pre-eclampsia, diabetes in pregnancy and postpartum bleeding. The charts show patients registered with the selected code in specialist healthcare each year. This does not measure how many people in the population have the condition, and codes cannot be summed to count unique patients.
2025: 879 registered patients. 90 more than in 2024. Changes may also reflect diagnosis, coding and healthcare use.
The chart includes its original source, unit of measurement, caveats and Womanhood Initiative credit. Missing values are not treated as zero.
| Year | Registered patients |
|---|---|
| 2017 | 870 |
| 2018 | 823 |
| 2019 | 748 |
| 2020 | 765 |
| 2021 | 797 |
| 2022 | 805 |
| 2023 | 886 |
| 2024 | 789 |
| 2025 | 879 |
Original source: FHI NPR, table 546, ICD-10 condition codes. Measure ANT_PAS, service area 9000, all providers (3). Figures for 2017–2025, retrieved and verified on 4 November 2026. This explorer includes seven selected pregnancy- and birth-related diagnosis codes. People may be included under multiple codes and must not be summed as unique patients. The sources do not provide figures broken down by sex or adjusted for population size here. These data concern contact with healthcare services and cannot be used to calculate prevalence or risk.
View original FHI tableOriginal extract and verification on GitHubContraception use figures tell us about dispensing of registered methods but cannot, on their own, say whether a pregnancy was planned or whether a person is protected against pregnancy.
Back to the topic overviewFHI · Norwegian Prescribed Drug Registry · hormonal contraception
The Norwegian Institute of Public Health reports that the proportion using hormonal contraception declined among women under 30 up to 2024. Do not compare age groups as if they had the same starting year: FHI uses 2019 as the comparison year for ages 16–19 and 25–29, and 2020 for ages 20–24.
5 percentage points lower in 2024 than in 2019. The difference is in percentage points, not a percentage change.
10 percentage points lower in 2024 than in 2020. The difference is in percentage points, not a percentage change.
6 percentage points lower in 2024 than in 2019. The difference is in percentage points, not a percentage change.
| Age | Earlier | 2024 |
|---|---|---|
| 16–19 years | 57 % (2019) | 52 % |
| 20–24 years | 70 % (2020) | 60 % |
| 25–29 years | 55 % (2019) | 49 % |
These are registry-based figures for hormonal contraceptives, not a measure of all contraception use or how many people are protected against pregnancy. Condom use and other non-hormonal methods cannot be calculated from these figures. FHI also reports increased use of long-acting methods among young women, but without separately verified annual figures we do not show a line for each method.
Original source: FHI, Medicine use in Norway, Figures 14 and 15FHI · Norwegian Prescribed Drug Registry · 2023–2025
Choose age group and medicine group. The figures show women who received medicine from a pharmacy, not how many actually use it for contraception. Some medicines may have other indications.
Number of women with recorded dispensing per 1,000 inhabitants in the age group
The bars are relative to the highest value in the selection. Read the exact rates on the right.
The same ATC category and year for each age group. Rates are per 1,000 women in the age group, not a measure of contraceptive use.
| Age | Women with dispensing | Per 1,000 |
|---|---|---|
| 15 - 19 years | 4,221 | 25.53 |
| 20 - 24 years | 5,740 | 35.64 |
| 25 - 29 years | 4,495 | 25.44 |
| 30 - 34 years | 5,124 | 26.86 |
| 35 - 39 years | 5,073 | 26.00 |
| 40 - 44 years | 4,509 | 24.88 |
| 45 - 49 years | 4,231 | 24.34 |
| Year | Women with dispensing | Per 1,000 |
|---|---|---|
| 2023 | 6,094 | 38.06 |
| 2024 | 5,962 | 37.04 |
| 2025 | 5,740 | 35.64 |
The medicine groups do not necessarily correspond to contraceptive methods as people describe them. We cannot sum the figures to count unique contraceptive users, and dispensing does not mean actual use. Condoms and other non-prescription methods are not included.
Original source: FHI Norwegian Prescribed Drug Registry, table 825. Source updated 03/03/2026. Open the source table
Figures from centres show contact with healthcare services. Population surveys also describe the experiences of people who have never sought help.
Back to the topic overviewNKVTS · Population survey
Sexual assault centres record contact with healthcare services. Population surveys can also shed light on the experiences of people who never sought help or reported the incident to the police.
Women who reported rape involving force or coercion
Men who reported the same
NKVTS interviewed 4,299 people aged 18–74 between June 2021 and June 2022. The study was published in 2023. The figures describe lifetime experiences, not incidents during a single calendar year. Self-reported experiences cannot be directly compared with the number of police reports or visits to sexual assault centres.
Source: NKVTS, 2023 prevalence studyCity of Oslo · Sexual Assault Centre
The Sexual Assault Centre provides emergency healthcare to people aged 14 and over who have experienced, or suspect they have experienced, sexual assault. The figures describe people who received care at the centre, not how many assaults occurred.
Number of registered patients per year
Bars start at zero. Figures refer to calendar years and are not adjusted for population size.
Patients in 2024
752
238 more registered patients than in 2020. This alone says nothing about changes in the prevalence of sexual assault.
| Year | Registered patients |
|---|---|
| 2020 | 514 |
| 2021 | 582 |
| 2022 | 744 |
| 2023 | 748 |
| 2024 | 752 |
A medical-record study of 744 registered visits to Oslo Sexual Assault Centre in 2022 examined attendance at medical follow-up. A total of 579 accepted follow-up. Of these, 444 (76.7 percent) attended at least one medical check-up during the study period. Among 274 patients whom the centre tried to contact after a missed appointment, 169 attended at least one check-up.
These figures concern registered visits to this centre in 2022, not follow-up attendance at every sexual assault centre in Norway. Researchers did not record unique patients and therefore could not identify any repeat visits by the same person. The study alone cannot determine how many additional patients attended because they were contacted again.
Patient figures 2020–2024: City of Oslo, Agency for Health, 2024 annual report, page 16. Read the annual report.
Follow-up study: Rogne and colleagues, 'Medical follow-up at Oslo Sexual Assault Centre', Journal of the Norwegian Medical Association, 2026. Read the study.
Limitations: The centre does not measure the prevalence of sexual assault in the population. It accepts patients from Oslo and cooperating municipalities, as well as others seeking emergency care. The number of registered patients is also not the same as the number of police reports, forensic examinations or unique incidents.
2025–2026: Comparable full-year figures for 2025–2026 are unavailable in this overview.
National survey · NORCE / NKLM
A survey conducted in autumn 2023 examined organisation, staffing, finances, emergency preparedness and follow-up at all 23 sexual assault centres included in the study. This is a survey of services, not a count of all sexual assaults in Norway.
Centres surveyed in 2023
23
NORCE interviewed management at all the centres in the survey.
Later overview
24
The Norwegian Directorate of Health lists 24 sexual assault centres in its more recent status report. The figures refer to different points in time and do not constitute a documented growth series.
Trend in visits · 2013–2023
+72 %
NORCE reports a 72 percent increase in visits to sexual assault centres over ten years. The report also includes a national trend figure for 2008–2023. We do not reproduce individual annual figures from it until the values and definitions of patients, cases and visits have been verified.
Source: NORCE / NKLM, Sexual Assault Centres 2023, report no. 2-2024, section 4.1.6, pages 18–19. This does not measure the prevalence of sexual assault.
2008
1,072
2022
2,450
Comparison of two documented individual years, not a complete time series. Shared scale from 0 to 2,500 cases.
NOU 2024: 4 reports these two national case figures from the National Centre for Emergency Primary Health Care. That corresponds to approximately 129 percent more registered cases. These figures concern contact with sexual assault centres, not the number of sexual assaults in the population.
Source: NOU 2024: 4, Chapter 15, Figure 15.1. This is not the same comparison period as NORCE's 72 percent for 2013–2023. The figures come from different periods and use different definitions. They therefore cannot be combined into a reliable year-by-year comparison.
The findings show differences in how services are organised. They do not show how many people were turned away, how long patients waited or whether a particular person received adequate care.
NORCE / NKLM: Survey of sexual assault centres (2023). The study was conducted in autumn 2023 and published in 2024. The main findings are based on interviews and reports from the centres.
Norwegian Directorate of Health: Survey of clinical forensic services for adults. The source lists 24 centres in a later status report.
NORCE also collects annual case figures and publishes a trend chart for 2008–2023. The report states that visits increased by 72 percent between 2013 and 2023. Without the exact annual figures, we cannot say how the increase was distributed across the individual years.
How do self-rated health, recorded health problems and healthcare use vary between groups? Association does not necessarily imply causation.
Back to the topic overviewFHI and Statistics Norway · 2025
FHI reports that the proportion of teenage girls and young women with eating disorders recorded in specialist healthcare increased over time, but that the trend has stabilised in recent years. These are people who have had a diagnosis recorded, not everyone with an eating disorder.
FHI publishes annual series for 2010–2025 by age and sex for diagnoses with ICD-10 code F50. Among boys, the recorded proportions were below 0.1 percent in all age groups. The exact age-disaggregated annual series appears in FHI's Figures 13 and 14, but is not reproduced here as a separate numerical chart.
A Norwegian study from 2023 found a prevalence of 9 percent among 16–19-year-olds. The result may be affected by the pandemic and by who responded. A population survey and registry figures measure different things and should therefore not be compared directly.
In Statistics Norway's 2025 health survey, 74 percent of women and 78 percent of men rated their health as good or very good. This means that a smaller proportion of women reported good health in this survey.
Shared bar scale: 0–100 percent. Self-reported health, not a diagnosis. Between 2015 and 2025, the proportion fell by four percentage points among women and three among men.
Source: Statistics Norway, Health conditions – Survey of Living Conditions 2025FHI · National Public Health Survey 2025
The proportion rating their own health as good or very good, by education and sex. The figures are age-adjusted and cover people over 25 who are not students.
Shared scale from 0 to 100 percent. Age-adjusted percentages, not numbers of people.
| Education | Women | Men |
|---|---|---|
| Compulsory education | 54.0 % | 60.3 % |
| Upper secondary education | 62.6 % | 65.2 % |
| Vocational tertiary education/higher education under two years | 69.8 % | 71.8 % |
| Higher education, 2–4 years | 76.5 % | 76.5 % |
| Higher education, more than four years | 82.9 % | 84.4 % |
Among women, the difference between the lowest and highest education categories is 28.9 percentage points. FHI found no clear differences between sexes within individual education groups. The figures show an association between education and health but cannot establish the cause. Sampling, weighting and self-reporting affect interpretation.
Source: FHI, National Public Health Survey 2025, Figure 2Here you will find original sources and topics that do not yet have a comparable data series. This is documentation, not additional findings.
Back to the topic overviewFor some areas of health, surveys and registry information exist, but not yet figures that can be compared consistently from year to year. This does not mean we lack knowledge about the conditions.
PCOS, vulvodynia, heavy menstrual bleeding and menopausal symptoms.
Registry data count people who have received a diagnosis, while population surveys may also capture those who have not received a diagnosis. The figures therefore concern different groups.
Source and further statisticsAnnual figures for girls and women broken down by age and diagnosis.
FHI shows changes over time and across age groups. Without exact annual figures, we cannot show the size of these changes in a separate detailed chart.
Source and further statisticsIncome, geography and healthcare use.
Differences by education are shown above. Income and residence may also matter for health and healthcare use, but must be compared within the same population group using the same unit of measurement.
Source and further statisticsSources and further reading
Here you will find links to statistics from FHI, the Norwegian Directorate of Health, Statistics Norway and Health Atlas. This is an overview of external data sources, not charts produced by Tidlignok. We describe what the sources contain and the limitations you should know about. Figures from different sources cannot always be compared directly.
FHI · Norwegian Patient Registry
Official waiting-list figures with waiting times, referrals and deadlines. Monthly figures are preliminary, whereas four-month and annual figures are official statistics.
Not the same as waiting times with contracted specialists. Distinguish between those still waiting and those who have begun receiving healthcare.
Norwegian Directorate of Health
Mean and median waiting time in somatic healthcare services.
The indicator is being revised. Changes in recording practices from June 2024 must be examined when comparing figures.
Norwegian Directorate of Health · SAMDATA
Use of specialist healthcare by area of residence, sex and age where the data allow.
Patients and contacts are different measures. An area of residence does not necessarily correspond to a county.
SKDE · Health Atlas
Gynaecological analyses of geographic variation in healthcare use, including operations for endometriosis.
High rates of treatment do not automatically mean better quality or access.
SSB
Published statistics on capacity, activity and resources in specialist healthcare.
Geographical breakdowns vary between series; breakdown by sex is not always possible.
Reviewed on 4 November 2026. We do not publish new figures without confirmed definitions, population, reference period and source.
When comparing sources, it is important to check who the figures describe, the period measured, and whether the data count patients, treatments or waiting times.